Related Experiment Videos
Antimicrobial agents in patients with renal insufficiency
Mayo Clinic Proceedings
|April 1, 1983
Summary
Renal impairment necessitates adjusting doses for many antimicrobial drugs, including penicillins, cephalosporins, and aminoglycosides. Careful monitoring and serum drug assays ensure safe and effective antimicrobial therapy in patients with reduced kidney function.
Area of Science:
- Pharmacology
- Nephrology
- Infectious Diseases
Background:
- Many antimicrobial agents require dose adjustments in patients with impaired renal function or anuria.
- Specific drug classes commonly affected include penicillins, cephalosporins, aminoglycosides, vancomycin, and trimethoprim-sulfamethoxazole.
Purpose of the Study:
- To provide guidelines for adjusting antimicrobial dosages in patients with compromised renal function.
- To highlight antimicrobial agents that may not require dose modification in the presence of normal hepatic function.
Main Methods:
- Review of antimicrobial agents requiring dosage adjustments based on renal function.
- Identification of antimicrobials potentially safe from dose adjustment if hepatic function is normal.
- Emphasis on the need for therapeutic drug monitoring via serum antimicrobial assays.
Main Results:
- Most penicillins, cephalosporins, aminoglycosides, vancomycin, and trimethoprim-sulfamethoxazole require dose reduction proportional to renal function.
- Chloramphenicol, clindamycin, rifampin, oxacillin, and nafcillin may not need dose adjustment with normal liver function.
- Initial doses serve as crude guidelines; subsequent adjustments based on serum assays are crucial.
Conclusions:
- Antimicrobial dosing must be individualized for patients with renal insufficiency.
- Therapeutic drug monitoring and close observation for efficacy and toxicity are essential.
- Accurate dose adjustment ensures optimal outcomes in patients with kidney dysfunction.